Transplant and Addiction Project (TAP) - 1
|ClinicalTrials.gov Identifier: NCT00249652|
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : April 14, 2015
|Condition or disease||Intervention/treatment||Phase|
|End Stage Liver Disease End Stage Renal Disease Substance-Related Disorders||Behavioral: TAP Other: TAU||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||41 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Drug Treatment for Transplant Candidates|
|Study Start Date :||September 2003|
|Actual Primary Completion Date :||June 2009|
|Actual Study Completion Date :||September 2009|
MI-based phone intervention.
12-session motivational interviewing-based telephone intervention.
Treatment As Usual
The usual care group will receive the same medical services they would otherwise receive if they were not in this study.
- Abstinence [ Time Frame: 3 month time frame ]
- Stage of Change, illness response, psychological stress [ Time Frame: 3 month time frame ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00249652
|United States, New York|
|Behavioral Science Research Unit|
|New York, New York, United States, 10025|
|Renal & Islet Transplant, Center for Liver Disease|
|New York, New York, United States, 10032|
|United States, Virginia|
|Liver Transplant Program|
|Richmond, Virginia, United States, 23298|
|Principal Investigator:||Deborah Haller||St. Luke's Roosevelt Hosp Cntr (New York)|